Titre : Cônes de croissance

Cônes de croissance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cônes de croissance : Questions médicales les plus fréquentes", "headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cônes de croissance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Axones", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } } }, "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "alternateName": "Growth Cones", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michihiro Igarashi", "url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi", "affiliation": { "@type": "Organization", "name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan." } }, { "@type": "Person", "name": "Daniel M Suter", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu." } }, { "@type": "Person", "name": "Yimin Zou", "url": "https://questionsmedicales.fr/author/Yimin%20Zou", "affiliation": { "@type": "Organization", "name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu." } }, { "@type": "Person", "name": "Jeffrey van Haren", "url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Snehal S Mahadik", "url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik", "affiliation": { "@type": "Organization", "name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Quantitative muscle magnetic resonance imaging depicts microstructural abnormalities but no signs of inflammation or dystrophy in post-COVID-19 condition.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36693812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ene.15709" } }, { "@type": "ScholarlyArticle", "name": "Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy - A systematic review.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36875457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1091185" } }, { "@type": "ScholarlyArticle", "name": "Experience of individualized nursing in patients with laryngeal squamous cell carcinoma combined with Helicobacter pylori infection after surgery.", "datePublished": "2023-02-14", "url": "https://questionsmedicales.fr/article/36781505", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00432-023-04627-z" } }, { "@type": "ScholarlyArticle", "name": "Mental health among children with long COVID during the COVID-19 pandemic.", "datePublished": "2023-02-14", "url": "https://questionsmedicales.fr/article/36786887", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00431-023-04854-z" } }, { "@type": "ScholarlyArticle", "name": "Measuring Articulatory Patterns in Amyotrophic Lateral Sclerosis Using a Data-Driven Articulatory Consonant Distinctiveness Space Approach.", "datePublished": "2023-02-14", "url": "https://questionsmedicales.fr/article/36787156", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-22-00320" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" }, { "@type": "ListItem", "position": 5, "name": "Axones", "item": "https://questionsmedicales.fr/mesh/D001369" }, { "@type": "ListItem", "position": 6, "name": "Cônes de croissance", "item": "https://questionsmedicales.fr/mesh/D020439" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cônes de croissance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cônes de croissance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cônes de croissance", "description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cônes de croissance", "description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cônes de croissance", "description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cônes de croissance", "description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cônes de croissance", "description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cônes de croissance", "description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un cône de croissance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les cônes de croissance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées." } }, { "@type": "Question", "name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour les cônes de croissance ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier." } }, { "@type": "Question", "name": "Peut-on évaluer la fonction des cônes de croissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Les cônes de croissance affectent-ils le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives." } }, { "@type": "Question", "name": "Comment les cônes de croissance sont-ils liés à la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques." } }, { "@type": "Question", "name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée." } }, { "@type": "Question", "name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des cônes de croissance ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils les cônes de croissance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement neuronal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le développement neuronal ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique." } }, { "@type": "Question", "name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale." } }, { "@type": "Question", "name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales." } }, { "@type": "Question", "name": "Le tabagisme maternel est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes." } }, { "@type": "Question", "name": "Le manque de soins prénatals est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques." } } ] } ] }

Sources (10000 au total)

Quantitative muscle magnetic resonance imaging depicts microstructural abnormalities but no signs of inflammation or dystrophy in post-COVID-19 condition.

Post-COVID-19 condition (PCC) has high impact on quality of life, with myalgia and fatigue affecting at least 25% of PCC patients. This case-control study aims to noninvasively assess muscular alterat... Quantitative muscle MRI was performed on a 3 Tesla MRI scanner of the whole legs in PCC patients compared to age- and sex-matched healthy controls, including a Dixon sequence to determine muscle fat f... Twenty PCC patients (female: n = 15, age = 48.8 ± 10.1 years, symptoms duration = 13.4 ± 4.2 months, body mass index [BMI] = 28.8 ± 4.7 kg/m... Quantitative muscle MRI did not depict any signs of ongoing inflammation or dystrophic process in the skeletal muscles in PCC patients. However, differences observed in muscle DTI depict microstructur...

Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy - A systematic review.

To describe the frequency of hypophysitis and hypopituitarism in cancer patients who are undergoing antineoplastic treatment with immunotherapy, as well as to describe the clinical, epidemiological, a... A systematic search of the literature in PubMed, Embase, Web of Science, ClinicalTrials.gov and Cochrane Controlled Register of Trials took place on May 8 and 9, 2020. Randomized and nonrandomized cli... A total of 239 articles were obtained, in which 963 cases of hypophysitis and 128 cases of hypopituitarism were found in a treated population of 30,014 individuals (3.20% and 0.42% of the evaluated po... The present review reported a frequency of hypophysitis and hypopituitarism of 3.20% and 0.42%, respectively, in the evaluated population. The clinical-epidemiological characteristics of patients affe... https://www.crd.york.ac.uk/prospero/, identifier CRD42020175864....

Experience of individualized nursing in patients with laryngeal squamous cell carcinoma combined with Helicobacter pylori infection after surgery.

To explore the effect of personalized nursing on the therapeutic effect on patients with laryngeal squamous cell carcinoma (LSCC) combined with Helicobacter pylori (HP) infection after surgery.... This study enrolled 46 patients with LSCC as research subjects. The patients were divided into an experimental group and a control group using the random number table method. Routine nursing was provi... Compared with the control group, the individualized nursing intervention reduced the incidence of ARs of esophageal reflux (P < 0.05) and improved nursing satisfaction (P < 0.05).... Individualized nursing intervention reduced the incidence of esophageal reflux ARs in patients with LSCC and HP infection after tracheotomy and improved both the therapeutic effect of the treatment an...

Measuring Articulatory Patterns in Amyotrophic Lateral Sclerosis Using a Data-Driven Articulatory Consonant Distinctiveness Space Approach.

The aim of this study was to leverage data-driven approaches, including a novel articulatory consonant distinctiveness space (ACDS) approach, to better understand speech motor control in amyotrophic l... Electromagnetic articulography was used to record tongue and lip movement data during the production of 10 consonants from healthy controls (... There was a significant relationship between the ACDS and intelligible speaking rate (area,... Our comprehensive approach is sensitive to early oromotor changes in response due to disease progression. The preserved articulatory consonant space may capture the use of compensatory adaptations to ... https://doi.org/10.23641/asha.22044320....

Exploring nitric oxide as a crucial prognostic biomarker of coronary artery disease.

The study aimed to examine if the polymorphism of the endothelial nitric oxide synthase (eNOS) gene variable number of tandem repeats (VNTR) and the serum NO levels are associated with CAD.... Case-control study, 70 CAD and 30 control subjects were enrolled. The eNOS gene polymorphism was measured by polymerase chain reaction-agarose gel electrophoresis and the serum NO was assessed by usin... Uncovering the area under curve (AUC) for serum NO, which was (0.6821), indicating that NO seemed to be a critical prognostic biomarker of CAD; also, glucose, serum creatinine and total bilirubin prov... The eNOS (ab) variant seems to be a protective CAD factor for patients. Low serum NO levels are another risk factor for the advancement of CAD, suggesting their involvement in atherosclerosis. The (a)...

Risk factors for Pneumocystis pneumonia with acute respiratory failure among kidney transplant recipients.

One of the rare life-threatening fungal infections is pneumocystis pneumonia (PCP). Immunocompromised patients are the main vulnerable population. We investigate the risk factors associated with the d... This is a retrospective, single-center, case-control study. PCP patients who are kidney transplant recipients and required high-flow oxygen support or mechanical ventilation between March 2009 and Feb... Among the total 2,330 kidney transplant recipients, 50 patients (2.1%) were diagnosed with PCP. Of these, 27 patients (54.0%) had severe PCP and 7 patients (14.0%) died, all of them were severe PCP pa... Patients who have lymphopenia at the time of hospital admission or have been recently treated with acute rejection are more likely to progress to severe PCP, requiring intensive monitoring and aggress...

Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009-2020.

The objective of this systematic review is to describe polysubstance studies and their prevalence estimates among pregnant people in the US.... This review was not subject to protocol preparation or registration with the International Prospective Register of Systematic Reviews (PROSPERO) because outcome data were not reported. The Preferred R... A total of 119 studies were included: 7 case-control studies, 7 clinical trials, 76 cohort studies, and 29 cross-sectional studies. Studies varied with respect to study design, time period, region, sa... Polysubstance use during pregnancy is common, especially with alcohol, marijuana, and/or tobacco/nicotine. Future research to assess polysubstance use during pregnancy could help better describe patte...

The Impact of Cervical Spinal Disease on Pharyngeal Swallowing Function.

Spinal pathology is very common with advancing age and can cause dysphagia; however, it is unclear how frequently these pathologies affect swallowing function. This study evaluates how cervical spinal... A retrospective case-control study was performed on 100 individuals with dysphagia as well as age-/gender-matched healthy controls (HCs) with available VFSS. Spinal anatomy of patients was classified ... Most patients with dysphagia had spinal pathology. Spinal pathology was judged to be the primary etiology of dysphagia in 16.9% of patients with abnormal spine pathology. Median EAT-10 scores were sta... Spinal pathology is commonly observed during VFSS and can contribute to dysphagia, resulting in worse swallowing-related outcomes when compared with HCs. Patients judged to have SAD tended to have bet...